2Goldenberg N, Kahn SR, Solgmoss S. Markers of coagulation and angiogenesis in cancer associated verous throm boembolism[J]. J Clin Oncol,2003,21(22) :4194-4199.
1Goldhaber SZ, Tapson VF. A prospective registry of 5, 451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol, 2004, 93(2) :259-262.
2Blom JW, Doggen CJ, Osanto S, et al. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA, 2005, 293 (6) :715-722.
3Blom JW, Osanto S, Rosendaal FR. The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma. J Thromb Haemost, 2004, 2 ( 10 ) : 1760- 1765.
4Smith JA Jr. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. J Urol, 2005, 174(4 Pt 1 ) :1300.
5Blom JW, Vanderschoot JP, Oostindier MJ, et al. Incidence of venous thrombosis in a large cohort of 66, 329 cancer patients: results of a record linkage study. J Thromb Haemost, 2006, 4(3) :529-535.
6Mandala M, Reni M, Cascinu S, et al. Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients. Ann Oncol, 2007, 18 ( 10 ) : 1660-1665.
7Rickles FR, Falanga A. Molecular basis for the relationship between thrombosis and cancer. Thromb Res, 2001, 102(6) :V215-224.
8Goldenberg N, Kahn SR, Solymoss S. Markers of coagulation and angiogenesis in cancer-associated venous thromboembolism. J Clin Oncol, 2003, 21 (22) :4194-4199.
9Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med, 2004, 350(23) :2335-2342.
10Lee AY, Levine MN, Butler G, et al. Incidence, risk factors, and outcomes of catheter- related thrombosis in adult patients with cancer. J Clin Oncol, 2006, 24(9) :1404-1408.
